Bayer keeps benefiting from euro weakness: report

BERLIN (Reuters) - German pharmaceuticals group Bayer keeps benefiting from the weak euro, though the region's deepening debt crisis is beginning to weigh on orders in some sectors, a Swiss newspaper…
Read the full story: Reuters: Health News